Metheptazine
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate | |
| Identifiers | |
| CAS Number |
469-78-3 |
| ATC code | none |
| PubChem | CID 3047717 |
| ChemSpider |
2310051 |
| UNII |
93X4R66P5A |
| ChEMBL |
CHEMBL2104520 |
| Synonyms | Metheptazine |
| Chemical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.36 g/mol |
| |
| |
| | |
Metheptazine is an opioid analgesic from the phenazepine family. It was developed by American Home Products in the 1950s.[1]
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
- ↑ US Patent 2740777 PROCESS FOR THE PREPARATION OF HEXAHYDRO-1,3-DIMETHYL- 4-PHENYLAZEPINE-4-CARBOXYLIC ACID, ETHYL ESTER
- ↑ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

